Evidence map›Paper›PMID 18032726›Full record

ArticleGenome research2008

Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.

Xavier Roca, Andrew J Olson, Atmakuri R Rao, Espen Enerly, Vessela N Kristensen, Anne-Lise Børresen-Dale, Brage S Andresen, Adrian R Krainer, Ravi Sachidanandam

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Genome research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. IndependentGenes · 2023
    Article
  14. Review
  15. Higher-order epistasis and phenotypic prediction.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Article
  18. Autosomal dominant optic atrophy: A novel treatment forMolecular therapy. Nucleic acids · 2021
    Article
  19. Article
  20. Enriched Alternative Splicing in Islets of Diabetes-Susceptible Mice.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Xavier RocaCold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.
Andrew J Olson
Atmakuri R Rao
Espen Enerly
Vessela N Kristensen
Anne-Lise Børresen-Dale
Brage S Andresen
Adrian R Krainer
Ravi Sachidanandam
Cold Spring Harbor Laboratory · USUniversity of Oslo · NOAarhus University · DK

Funding

VIRAL TRANSACTIVATIONP01CA013106 · NCI · COLD SPRING HARBOR LABORATORY · PI William Richard McCombie · 1985 to 2026
$116.8M
NCI NIH HHS CA13106NCI NIH HHS P01 CA013106
6 · The paper itself

Abstract

Many human diseases, including Fanconi anemia, hemophilia B, neurofibromatosis, and phenylketonuria, can be caused by 5'-splice-site (5'ss) mutations that are not predicted to disrupt splicing, according to position weight matrices. By using comparative genomics, we identify pairwise dependencies between 5'ss nucleotides as a conserved feature of the entire set of 5'ss. These dependencies are also conserved in human-mouse pairs of orthologous 5'ss. Many disease-associated 5'ss mutations disrupt these dependencies, as can some human SNPs that appear to alter splicing. The consistency of the evidence signifies the relevance of this approach and suggests that 5'ss SNPs play a role in complex diseases.

Indexed as

Polymorphism, Single NucleotideAnimalsDatabases, Nucleic AcidGenetic Diseases, InbornGenome, HumanHumansMiceRNA Splice SitesRNA SplicingRNA Splice Sites

Identifiers

PMID18032726
PMCPMC2134769
OpenAlexW2148768032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.